ZVRA
ZEVRA THERAPEUTICS, INC.
+0.23 (+1.95%)12.03USD886K成交股數714M市值12.8本益比(近四季)5.3股價營收比+53.3%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 39.7M+53% | 36.2M+78% | 34.1M+824% | 26.1M+486% | 25.9M+656% | 20.4M+58% | 3.7M+28% | 4.4M-47% | 3.4M | 12.9M | 2.9M | 8.5M |
| 營業成本 | 1.5M | 1.9M | 1.5M | 1.2M | 12.4M | 1.3M | 2.3M | 3.6M | 175K | 2.0M | 144K | 677K |
| 毛利 | 38.1M+182% | 34.3M+80% | 32.6M+2242% | 24.8M+2734% | 13.5M+315% | 19.1M+74% | 1.4M-49% | 876K-89% | 3.3M | 10.9M | 2.8M | 7.8M |
| 毛利率 | 96.2% | 94.8% | 95.5% | 95.2% | 52.2% | 93.4% | 37.7% | 19.7% | 94.9% | 84.5% | 95.0% | 92.0% |
| 研發費用 | 4.5M | 4.4M | 2.6M | 3.4M | 3.4M | 3.3M | 10.9M | 10.5M | 12.3M | 11.4M | 12.3M | 7.4M |
| 銷售管理費用 | 16.6M | 20.8M | 20.4M | 16.9M | 20.8M | 19.5M | 16.2M | 12.6M | 9.9M | 14.7M | 5.8M | 6.6M |
| 營業利益 | 16.8M-124% | 52.1M-1073% | 9.3M-134% | 4.1M-117% | −71.0M+247% | −5.4M-65% | −27.3M+78% | −23.8M+281% | −20.5M | −15.2M | −15.4M | −6.3M |
| 營業利益率 | 42.3% | 144.0% | 27.3% | 15.9% | -274.5% | -26.3% | -739.0% | -534.8% | -598.1% | -117.3% | -530.7% | -73.8% |
| 稅後淨利 | 8.8M-88% | 37.9M-1323% | 12.2M-137% | −544K-97% | 74.7M-549% | −3.1M-84% | −33.2M+220% | −19.9M+674% | −16.6M | −19.9M | −10.4M | −2.6M |
| 淨利率 | 22.1% | 104.6% | 35.6% | -2.1% | 288.7% | -15.2% | -899.2% | -447.9% | -485.3% | -154.0% | -358.1% | -30.4% |
| 稀釋 EPS | 0.14-88% | 0.60-1100% | 0.21-130% | -0.01-98% | 1.21 | -0.06 | -0.69 | -0.48 | – | – | – | – |
| 稀釋股數 | 61.3M | 60.2M | 57.3M | 56.0M | 56.3M | 54.1M | 47.8M | 41.9M | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 145M | 95.6M | 62.4M | 54.4M | 47.7M | 37.3M | 54.0M | 39.3M | 42.8M | 43.0M | 43.3M | 66.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | 16.1M | 3.1M | 1.3M |
| 存貨 | 2.4M | 2.3M | 1.7M | 1.4M | 1.1M | 2.6M | – | – | – | 0.00 | – | – |
| 總資產 | 303M | 279M | 285M | 270M | 256M | 173M | 192M | 144M | 151M | 172M | 139M | 106M |
| 有息負債 | 0.00 | 0.00 | 61.9M | 61.3M | 60.7M | 60.1M | 58.9M | 58.3M | – | 5.1M | – | – |
| 總負債 | 85.1M | 72.8M | 130M | 137M | 139M | 132M | 122M | 112M | 102M | 110M | 71.5M | 37.0M |
| 股東權益 | 218M | 206M | 155M | 133M | 117M | 41.0M | 69.8M | 32.5M | 48.8M | 61.9M | 61.5M | 58.9M |
| 負債比 | 28.1% | 26.1% | 45.7% | 50.7% | 54.3% | 76.2% | 63.6% | 77.5% | 67.7% | 64.1% | 51.5% | 35.1% |
| 淨現金(現金 − 有息負債) | 145M | 95.6M | 478K | −6.9M | −13.0M | −22.8M | −4.9M | −19.1M | – | 38.0M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 6.1M-175% | – | – | – | −8.2M | – | – | −16.2M | – | – | – |
| 資本支出 | – | 35K | – | – | – | 99K | – | – | 0.00 | – | – | – |
| 自由現金流 | – | 6.1M-173% | – | – | – | −8.3M | – | – | −16.2M | – | – | – |
| 折舊攤銷 | – | 368K | – | – | – | 1.6M | – | – | 1.6M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 16.9% | – | – | – | -40.8% | – | – | -472.0% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 106M
| Reportable | 106M | 100.0% | +350.9% |
|---|
產品／服務2025 年度 · 88.2M
| MIPLYFFA | 87.4M | 99.1% | +765.3% |
|---|---|---|---|
| Olpruva | 800K | 0.9% | +700.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 106M | +350.9% | 83.2M | 78.2% | 1.35 | −2.4M |
| FY2024 | 23.6M | -14.0% | −106M | -446.9% | -2.28 | −69.7M |
| FY2023 | 27.5M | +170.3% | −46.0M | -167.7% | – | −33.8M |
| FY2022 | 10.2M | -64.5% | −26.8M | -263.5% | – | −18.8M |
| FY2021 | 28.7M | +115.6% | −8.6M | -29.9% | -2.11 | 10.3M |
| FY2020 | 13.3M | +3.5% | −12.8M | -96.0% | -3.21 | −2.0M |
| FY2019 | 12.8M | – | −24.5M | -191.0% | -13.23 | −23.8M |
| FY2018 | 0.00 | – | −56.5M | –% | -3.15 | −54.2M |